Brenda S Morse

This inventor holds 19 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 4 EPO patents. Top assignees: Mimedx Group, Inc., Cryolife, Inc., Osteotech, Inc.. Active years: 1991-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Brenda S Morse. Retrieved from https://idiyas.com/inventor/brenda-s-morse

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19 (Patent Applications = 1)

% Patents Active = 94.7

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 5)

Average Co-Inventor Count = 4.0

ph-index = 8

Forward Citations = 728(Granted Patents)

Location History:

Kennesaw, GA (US) (2022)
Marietta, GA (US) (2019 - 2023)
Chamblee, GA (US) (1991 - 2024)

Company Filing History:

Years Active: 1991-2026

Loading Chart...

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12758590 - Micronized placental tissue compositions and methods of making and using the same (2026-10-13),

2. 11931384 - Micronized placental tissue compositions and methods of making and using the same (2024-03-19),

3. 11602549 - Laminated tissue grafts composed of Wharton's jelly and methods of making and using the same (2023-03-14),

4. 11338063 - Placental tissue grafts modified with a cross-linking agent and methods of making and using the same (2022-05-24),

5. 11235007 - Micronized placental tissue compositions and methods of making and using the same (2022-02-01),

6. 11219647 - Micronized placental tissue compositions and methods of making and using the same (2022-01-11),

7. 11103536 - Micronized placental tissue compositions and methods of making and using the same (2021-08-31),

8. 10869952 - Tissue grafts modified with a cross-linking agent and method of making and using the same (2020-12-22),

9. 10869951 - Tissue grafts modified with a cross-linking agent and method of making and using the same (2020-12-22),

10. 10376546 - Micronized placental tissue compositions and methods of making and using the same (2019-08-13),

11. 10350049 - Laminated tissue grafts composed of Wharton's jelly and methods of making and using the same (2019-07-16),

12. 10232085 - Tissue grafts modified with a cross-linking agent and method of making and using the same (2019-03-19),

13. 10105398 - Micronized placental tissue compositions and methods of making and using the same (2018-10-23),

14. 10105397 - Micronized placental tissue compositions and methods of making and using the same (2018-10-23),

15. 5513662 - Preparation of bone for transplantation (1996-05-07),

Title: The Innovative Contributions of Brenda S. Morse

Introduction

Brenda S. Morse, an accomplished inventor based in Chamblee, GA, holds an impressive portfolio of 18 patents. Her groundbreaking work primarily focuses on the medical applications of human tissue and its innovative uses in healthcare. Brenda has made significant strides in the field, contributing her expertise to enhance the performance of various medical materials.

Latest Patents

Among her latest inventions are two notable patents. The first is titled "Micronized placental tissue compositions and methods of making and using the same." This patent describes compositions composed of micronized placental components with numerous medical applications. It includes methods for producing and utilizing these micronized compositions.

The second patent, "Laminated tissue grafts composed of Wharton's jelly and methods of making and using the same," details the creation of tissue grafts derived from the placenta that exhibit improved physical and biological properties. This innovation incorporates a first membrane composed of Wharton's jelly, laminated with amnion, chorion, or a combination thereof, significantly enhancing the performance of various soft tissue substitutes.

Career Highlights

Brenda S. Morse has played an instrumental role in advancing medical technology through her work at leading companies such as MiMedx Group, Inc. and CryoLife, Inc. Her contributions have helped to push the boundaries of what is possible in regenerative medicine and tissue engineering.

Collaborations

Throughout her career, Brenda has collaborated with several talented professionals, including Somaly Sith and Randall Spencer. These partnerships exemplify the collaborative spirit that often fosters innovation and progress within the field.

Conclusion

Brenda S. Morse’s dedication to developing innovative medical solutions positions her as a key figure in the advancement of tissue-based therapies. Her extensive patent portfolio reflects a commitment to improving patient outcomes through cutting-edge research and development. With her expertise and pioneering inventions, Brenda continues to inspire future generations of inventors and innovators in the healthcare sector.

Profile summary based on public USPTO records.